Skip to content

Clinical trials

Active, not recruiting Lung Neoplasms trials in Taiwan

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lung Neoplasms Status: Active, not recruiting Country / region: Taiwan Clear all

22 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20141
20171
20181
20212
20226
20233
20248

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Active, not recruiting22

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca3
Novartis Pharmaceuticals3
Eli Lilly and Company2
Academia Sinica, Taiwan1
Amgen1
Boehringer Ingelheim1
Changhua Christian Hospital1
Genmab1
Gilead Sciences1
Hoffmann-La Roche1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lung Neoplasms22
Carcinoma, Non-Small-Cell Lung14
Colonic Neoplasms4
Colorectal Neoplasms4
Neoplasm Metastasis4
Esophageal Neoplasms3
Lung Diseases3
Neoplasms3
Ovarian Neoplasms3
Rectal Neoplasms3

Trials

Showing 1 to 22 of 22. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.